Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial
来那度胺治疗背景下的第二原发性恶性肿瘤:一项对参与 Myeloma XI 试验的 2732 例多发性骨髓瘤患者的分析
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2016.114
Jones, J R; Cairns, D A; Gregory, W M; Collett, C; Pawlyn, C; Sigsworth, R; Striha, A; Henderson, R; Kaiser, M F; Jenner, M; Cook, G; Russell, N H; Williams, C; Pratt, G; Kishore, B; Lindsay, J; Drayson, M T; Davies, F E; Boyd, K D; Owen, R G; Jackson, G H; Morgan, G J